The First Clinical College of Chongqing Medical University, China.
Department of Psychiatry, The First Affiliated Hospital of Chongqing Medical University, China.
J Telemed Telecare. 2022 Feb;28(2):83-95. doi: 10.1177/1357633X20917816. Epub 2020 Apr 19.
Postpartum depression (PPD) is a common psychiatric condition during the postnatal period that negatively impacts the well-being of both the mother and her infant. This study describes a systematic review and preliminary meta-analysis to assess the efficacy of mobile health (mHealth) interventions, which is defined as the use of portable electronic devices to support public health and medical practice, in addressing depressive symptoms among postpartum women.
Databases including PubMed, PsycINFO, the Cochrane Library, Embase and ClinicalTrials.gov were searched for randomized controlled trials (RCTs) assessing the effectiveness of mHealth interventions on PPD from database inception to December 2019.
The initial search identified 754 studies, of which, 11 studies fulfilled the inclusion criteria. These studies evaluated four types of distinct mHealth interventions and involved 2424 participants across six countries. Pooled results demonstrated that compared to the controls, the Edinburgh Postnatal Depression Scale score decreased in the mHealth intervention group (mean difference: -1.09, 95% confidence interval: -1.39 to -0.79).
Our study suggested that mHealth interventions may be a promising tool to complement routine clinical care in the prevention and treatment of PPD, but the clinical effectiveness of mHealth interventions needs to be better established. While most studies focused on telephone-based interventions, recent researches have also suggested the superiority and effectiveness of short messaging service (SMS) and smartphone applications, but the exact efficacy needs further evaluation. Therefore, more high-quality RCTs on app-based and SMS-based interventions are needed before the large-scale roll-out of these interventions in clinical practice.
产后抑郁症(PPD)是一种常见的产后精神疾病,会对母婴双方的健康产生负面影响。本研究描述了一项系统评价和初步的荟萃分析,以评估移动健康(mHealth)干预措施在解决产后妇女抑郁症状方面的疗效。mHealth 干预措施是指使用便携式电子设备来支持公共卫生和医疗实践。
从数据库成立到 2019 年 12 月,我们在 PubMed、PsycINFO、Cochrane 图书馆、Embase 和 ClinicalTrials.gov 等数据库中搜索了评估 mHealth 干预措施对 PPD 有效性的随机对照试验(RCT)。
最初的搜索确定了 754 项研究,其中 11 项研究符合纳入标准。这些研究评估了四种不同类型的 mHealth 干预措施,涉及六个国家的 2424 名参与者。汇总结果表明,与对照组相比,mHealth 干预组的爱丁堡产后抑郁量表评分降低(平均差异:-1.09,95%置信区间:-1.39 至 -0.79)。
我们的研究表明,mHealth 干预措施可能是一种有前途的工具,可以补充常规临床护理,用于预防和治疗 PPD,但 mHealth 干预措施的临床效果需要更好地确定。虽然大多数研究都集中在基于电话的干预措施上,但最近的研究也表明了短信息服务(SMS)和智能手机应用程序的优越性和有效性,但确切的疗效需要进一步评估。因此,在这些干预措施在临床实践中大规模推广之前,需要进行更多基于应用程序和短信的干预措施的高质量 RCT。